celecoxib
Preliminary        data suggest that celecoxib, a highly selective COX-2 inhibitor, is superior to       placebo and similar to traditional NSAIDs in the short-term treatment of pain due       to osteoarthritis, although it has been associated with adverse effects such as       headache, change in bowel habits, abdominal discomfort, and dizziness.
Preliminary        data suggest that  @SUBJECT$  @PREDICAT$  @OBJECT$ , is superior to       placebo and similar to traditional NSAIDs in the short-term treatment of pain due       to osteoarthritis, although it has been associated with adverse effects such as       headache, change in bowel habits, abdominal discomfort, and dizziness.